Acute Care and Trauma Flashcards
<p>Define acute kidney injury (AKI).</p>
<p>Acute kidney injury was previously known as acute renal failure (ARF). It is characterised by an <strong>ACUTE DECLINE IN RENAL FUNCTION</strong>. This leads to an increase in serum creatinine and a decrease in urine production/outflow.</p>
<p>Explain the aetiology/risk factors of acute kidney injury (AKI).</p>
<p></p>
<p>Sepsis<br></br>Cardiovascular collapse<br></br>Congestive heart failure<br></br>Major surgery<br></br>Nephrotoxins (such as antibiotics, intravenous contrast, or other drugs)<br></br>Urinary outflow obstruction</p>
<p>Summarise the epidemiology of acute kidney injury (AKI).</p>
<p>Among people hospitalised in 2014 with AKI, 40% also had diabetes.<br></br>In the intensive care unit (ICU), the incidence of AKI is higher.<br></br>Acute tubular necrosis (ATN) accounts for 45% of cases of AKI.<br></br></p>
<p>Recognise the presenting symptoms of acute kidney injury (AKI). Recognise the signs of acute kidney injury (AKI) on physical examination.</p>
<p></p>
<p></p>
<p>Flank pain<br></br>Haematuria<br></br>Oedema<br></br>Lethargy<br></br>Uraemia<br></br>Decreased urine output<br></br>AKI can be asymptomatic and is usually defined by lab tests.</p>
<p>Identify appropriate investigations for acute kidney injury (AKI) and interpret the results.</p>
<p>Basic metabolic profile (including urea and creatinine). Ratio of serum urea to creatinine.<br></br>Urinalysis.<br></br>Urine culture<br></br>FBC<br></br>Fractional excretion of sodium<br></br>Fractional excretion of urea<br></br>Urinary eosinophil count<br></br>Venous blood gases<br></br>Fluid challenge<br></br>Bladder catheterisation<br></br>Urine osmolality<br></br>Urine sodium concentration<br></br>CXR, ECG</p>
<p>Generate a management plan for acute kidney injury (AKI).<br></br></p>
<p>Treat the underlying cause</p>
<p>Identify the possible complications of acute kidney injury (AKI) and its management.<br></br></p>
<p>- Hyperkalaemia<br></br>- Heart failure<br></br>Give calcium gluconate to stabilise the myocardium. Then give a bolus of insulin with 20% dextrose, 100ml.</p>
<p>- Uraemia<br></br>- Metabolic acidosis<br></br>Give dialysis.<br></br></p>
<p>Summarise the prognosis for patients with acute kidney injury (AKI).<br></br></p>
<p>Recovery for AKI is variable and depends on the cause of injury and the severity and duration of AKI.<br></br></p>
<p>Define acute respiratory distress syndrome.<br></br></p>
<p>Acute respiratory distress syndrome (ARDS) is a <strong>NON-CARDIOGENIC PULMONARY OEDEMA</strong> and <strong>DIFFUSE LUNG INFLAMMATION SYSTEM</strong> that often complicates critical illness.</p>
<p>Explain the aetiology/risk factors of acute respiratory distress syndrome.<br></br></p>
<p> Sepsis with pulmonary origin.
Other conditions associated with ARDS include aspiration, inhalation injury, acute pancreatitis, trauma, burns, pulmonary contusion, transfusion-related lung injury, cardiopulmonary bypass, fat embolism, disseminated intravascular coagulation, and drug overdose.<br></br></p>
<p>Critical illness, cigarette smoking, and alcohol use are predisposing factors for ARDS. </p>
<p>Summarise the epidemiology of acute respiratory distress syndrome.<br></br></p>
<p>Overall, 10% to 15% of patients admitted to the intensive care unit meet the criteria for ARDS, with an increased incidence among mechanically ventilated patients meeting the criteria for ARDS.<br></br>Mortality is between 40% and 50%.<br></br></p>
<p>Recognise the presenting symptoms of acute respiratory distress syndrome.</p>
<p>SOB<br></br>Fatigue<br></br>Discolouration of nails<br></br>Rapid resp rate<br></br>Tachycardia<br></br>Fever<br></br></p>
<p>Recognise the signs of acute respiratory distress syndrome on physical examination.<br></br></p>
<p>Low oxygen saturation<br></br>Acute respiratory failure<br></br>Dyspnoea<br></br>Increased respiratory rate<br></br>Pulmonary crepitations<br></br>Low lung compliance<br></br>Fever, cough, pleuritic chest pain<br></br>(Frothy sputum)<br></br></p>
<p>Identify appropriate investigations for acute respiratory distress syndrome and interpret the results.<br></br></p>
<p>CXR - New onset of bilateral opacities that is not fully explained by effusions, lobar/lung collapse.<br></br>ABG - A PaO₂/FiO₂ (inspired oxygen) ratio of ≤300 on positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥5 cm H₂O is part of the diagnostic criteria for ARDS.<br></br>Sputum culture<br></br>Blood culture<br></br>Urine culture<br></br>Amylase and lipase</p>
<p>Define adrenal insufficiency.<br></br></p>
<p>Addison's disease, or primary adrenal insufficiency, is a disorder that affects the adrenal glands, causing decreased production of adrenocortical hormones (cortisol, aldosterone, and dehydroepiandrosterone).<br></br></p>
<p>Explain the aetiology/risk factors of adrenal insufficiency. Summarise the epidemiology of adrenal insufficiency.<br></br></p>
<p>TB is the most common cause worldwide, but in the UK, the most common cause is autoimmune disease.<br></br>Less common causes are infections (e.g. Pseudomonas aeruginosa or meningococcus) or drugs (e.g. warfarin).<br></br></p>
<p>Recognise the presenting symptoms of adrenal insufficiency.<br></br></p>
<p>Fatigue<br></br>Anorexia<br></br>Weight loss<br></br>Hyperpigmentation<br></br></p>
<p>Recognise the signs of adrenal insufficiency on physical examination.<br></br></p>
<p>Hypotension (can be Addisonian crisis).<br></br>Nausea<br></br>Vomiting<br></br></p>
<p>Identify appropriate investigations for adrenal insufficiency and interpret the results.<br></br></p>
<p>Serum electrolytes - hyponatraemia, hyperkalaemia, can rarely be hypercalcaemia<br></br>Blood urea<br></br>FBC - anaemia is present in 40% of patients.<br></br>Morning serum cortisol - cortisol should be high in the morning.<br></br></p>
<p>Generate a management plan for adrenal insufficiency.<br></br></p>
<p><strong>ACUTE</strong><br></br>IV Hydrocortisone 50-100mg for 1-3 days</p>
<p><strong>STABLE</strong><br></br>Hydrocortisone: 15-30 mg/day orally given in 2 divided doses with two-thirds of the total dose given in the morning (around 8 a.m.) and one third in the afternoon (noon to 4 p.m.)<br></br>OR<br></br>Prednisolone: 2.5 to 5 mg orally once daily</p>
<p>AND</p>
<p>Fludrocortisone: 0.1 to 0.2 mg orally once daily<br></br></p>
<p>Identify the possible complications of adrenal insufficiency and its management.<br></br></p>
<p>Hyperkalaemia: Give calcium gluconate, bolus IV insulin and 20% dextrose, 100ml.<br></br>Secondary Cushings’ syndrome: due to over-replacement of steroids.<br></br>Osteoporosis due to long term use of steroids.<br></br>Hypertension due to excessive mineralocorticoid replacement.<br></br></p>
<p>Summarise the prognosis for patients with adrenal insufficiency.<br></br></p>
<p>Patients are generally ok once they start treatment and stay on life-long replacement.<br></br>Adherence is high since non-adherence results in uncomfortable symptoms.<br></br></p>
<p>Define alcohol withdrawal.</p>
<p>Alcohol withdrawal syndrome (AWS), commonly referred to as 'the shakes', occurs in patients with alcohol dependence when their daily alcohol consumption is decreased or stopped. The syndrome typically begins within 4 to 12 hours after the patient's last drink, and may progress to potentially fatal <strong>delirium tremens</strong>.<br></br></p>
<p>Explain the aetiology of alcohol withdrawal.</p>
<p>Chronic alcohol use results in up-regulation of postsynaptic NMDA receptors and down-regulation of post-synaptic GABA receptors. A decrease in blood ethanol concentration due to abrupt cessation in alcohol consumption results in an imbalance between stimulatory (NMDA) and inhibitory (GABA) systems in the central nervous system. Excessive stimulatory effect leads to the development of the clinical signs and symptoms of AWS.</p>
<p>Explain the risk factors of alcohol withdrawal.</p>
<p>Risk factors include having a history of AWS or delirium tremens, as well as sudden withdrawal of alcohol.</p>
<p>Summarise the epidemiology of alcohol withdrawal.</p>
<p>In the US, the 2016 National Survey on Drug Use and Health found that 5.2% of adults over 26 years, 10.7% of adults aged 18-25 years, and 2.0% of youths (aged 12 to 17 years) suffer from alcohol use disorder.<br></br>It is estimated that of these alcohol-dependent patients, approximately 50% will experience symptoms of alcohol withdrawal upon reduced alcohol intake.</p>
<p>Recognise the presenting symptoms of alcohol withdrawal. Recognise the signs of alcohol withdrawal.</p>
<p>Hallucinations<br></br>Change in mental status<br></br>Tremor<br></br>Nausea and vomiting<br></br>Hypertension<br></br>Seizures</p>
<p>Identify appropriate investigations for alcohol withdrawal and interpret the results.</p>
<p>Serum urea and creatinine<br></br>Liver function tests<br></br>Ethanol<br></br>Electrolyte panel<br></br>FBC<br></br>CT of head<br></br>CXR</p>
<p>Generate a management plan for alcohol withdrawal.</p>
<p>Benzodiazepine or clomethiazole (+ supportive care)</p>
<p><u>Adjunct:</u><br></br>Phenobarbital<br></br>Vitamin supplementation</p>
<p>Identify the possible complications of alcohol withdrawal and its management.</p>
<p>Over-sedation<br></br>Delirium tremens<br></br>Alcohol withdrawal seizures<br></br>Status epilepticus<br></br>Death</p>
<p>Summarise the prognosis for patients with alcohol withdrawal.</p>
<p>Patients may complain of persistent insomnia and autonomic symptoms for a few months after acute withdrawal phase. These symptoms usually last about 6 months. About 50% of patients remain abstinent for a year.</p>
<p>Define anaphylaxis.<br></br></p>
<p><strong>An acute, systemic and life-threatening allergic response to a trigger </strong>caused by the release of immune and inflammatory mediators from basophils and mast cells. At least two organ systems are involved, such as the skin, the upper and lower airways, and the cardiovascular, neurological, and gastrointestinal systems, in this order of priority or in combination.<br></br></p>
<p>Explain the aetiology/risk factors of anaphylaxis.<br></br></p>
<p>Exposure to allergen in pre-sensitised individuals is the cause of immune-mediated anaphylaxis. Common allergens include drugs, foods, and insect stings, but exercise with or without the presence of an allergen may also be a trigger. Sometimes, a cofactor (such as an NSAID, alcohol, or another food) is required to provoke food-associated and exercise-induced anaphylaxis.<br></br>The most common trigger (up to ⅓ of cases) is food.<br></br></p>
<p>Summarise the epidemiology of anaphylaxis.<br></br></p>
<p>Anaphylaxis is under-reported and it is difficult to estimate as study definitions and criteria are not always comparable. The incidence of food allergic reactions that are coded as anaphylaxis is highest in young children. In children, food allergy is most prevalent in the industrialised world and the emerging economies of southeast Asia, possibly due to an increased exposure to processed food.<br></br></p>
<p>Recognise the presenting symptoms of anaphylaxis.<br></br></p>
<p>Rapidly progressive upper airway obstruction<br></br>Rash<br></br>Bronchospasm<br></br>Hypotension or cardiovascular collapse<br></br></p>
<p>Recognise the signs of anaphylaxis on physical examination.</p>
<p>The patient appears agitated, confused, and either flushed or pale. Neurological manifestations also include dizziness, visual disturbances, tremor, disorientation, syncope, and seizures.<br></br>Wheezing, an over-inflated chest, the use of accessory muscles, and preference for the forward-leaning position point to bronchoconstriction. Cardiovascular collapse may occur in addition to hypotension.<br></br>Nearly all adults will show skin manifestations of systemic mediator release, such as rash, erythema, or urticaria. These features might be overshadowed by the more dramatic respiratory and cardiovascular symptoms. Abdominal pain, nausea, vomiting, and diarrhoea are common symptoms.<br></br></p>
<p>Identify appropriate investigations for anaphylaxis and interpret the results.<br></br></p>
<p>During the anaphylactic shock, no investigations are useful as they take too long.<br></br>Serum tryptase level.<br></br></p>
<p>Generate a management plan for anaphylaxis. Identify the possible complications of anaphylaxis and its management.<br></br></p>
<p><strong>INITIAL</strong><br></br>Cardiorespiratory assessment + supportive measures<br></br>IM adrenaline (epinephrine)<br></br>Assess and secure airway<br></br>IV normal saline</p>
<p><strong>Cardiopulmonary arrest</strong><br></br>CPR and IV adrenaline (epinephrine)</p>
<p><strong>Severe hypotension</strong><br></br>IV adrenaline (epinephrine)<br></br>IV glucagon</p>
<p><strong>Persistent respiratory symptom</strong><br></br>Inhaled beta-2 agonist</p>
<p><strong>Symptomatic hives and rhinorrhoea</strong><br></br>H1 antagonist and H2 antagonist</p>
<p><strong>Post-emergency stabilisation</strong><br></br>Corticosteroids<br></br></p>
<p>Summarise the prognosis for patients with anaphylaxis.</p>
<p>Individuals with previous reactions are at higher risk for recurrence. However, the severity of the previous reaction does not necessarily predict the severity of a subsequent reaction.<br></br></p>
<p>Define aspirin overdose.</p>
<p>Potentially fatal poisoning occurring as a result of ingestion or, rarely, topical exposure to salicylates. Can present acutely or indolently with more chronic exposure.</p>
<p>Explain the aetiology/risk factors of aspirin overdose.</p>
<p>The most common source of salicylate poisoning is aspirin (acetylsalicylic acid), which is rapidly hydrolysed to salicylate in the gastrointestinal tract and bloodstream.</p>
<p>Summarise the epidemiology of aspirin overdose.</p>
<p>In the UK, deaths by suicidal overdose of analgesics, including salicylates, were reduced by 22% in the year immediately after the introduction in 1998 of legislation limiting the pack size of analgesics that could be purchased.</p>
<p>Recognise the presenting symptoms of aspirin overdose. Recognise the signs of aspirin overdose on physical examination.</p>
<p>Nausea, vomiting, haematemesis, epigastric pain<br></br>Fever and diaphoresis<br></br>Shortness of breath<br></br>Tachypnoea, hyperpnoea, Kussmaul's respirations<br></br>Tinnitus and/or deafness<br></br>Malaise and/or dizziness<br></br>Movement disorders, asterixis, stupor<br></br>Confusion and/or delirium (irritability, hallucinations)<br></br>Coma and/or papilloedema<br></br>Seizures</p>
<p>Identify appropriate investigations for aspirin overdose and interpret the results.</p>
<p>ABG<br></br>Serum electrolyte panel<br></br>Serum salicylate level<br></br>Serum urea and creatinine<br></br>Serum ketones<br></br>Blood glucose<br></br>FBC<br></br>Serum LFTs<br></br>Serum PT, activated PTT, INR<br></br>Toxicology screen<br></br>CXR<br></br>ECG</p>
<p>Define asthma.<br></br></p>
<p>Asthma is a chronic inflammatory airway disease characterised by intermittent airway obstruction and hyper-reactivity.<br></br></p>
<p>Explain the aetiology/risk factors of asthma.<br></br></p>
<p>Patients' genetic make-up may predispose them to hyper-responsiveness to environmental aetiological triggers. Those triggers include viral infections (e.g. rhinovirus, respiratory syncytial virus, human metapneumovirus, and influenza virus), bacterial infections (e.g. Mycoplasma pneumoniae or Chlamydia pneumoniae), allergen exposure (e.g. tree, grass, or weed pollen; fungi; or indoor allergens), occupational exposures (e.g. animal or chemical), food additives and chemicals (e.g. metabisulfites), irritants, or aspirin in predisposed people.<br></br></p>
<p>Summarise the epidemiology of asthma.<br></br></p>
<p>Asthma affects approximately 30 million people in Europe and more than 25 million people in the US. The global burden is reported to be 300 million people, potentially increasing to 400 million by 2025. In 2010, overall asthma prevalence in the US was 8.4%.<br></br></p>
<p>Recognise the presenting symptoms of asthma.<br></br></p>
<p>Recurrent episodes of dyspnoea, chest tightness, wheezing, or coughing typically occur.<br></br>The patient's medical history may help to identify allergen exposures that worsen asthma: for example, episodes may be exacerbated by exposure to irritants such as tobacco smoke or fumes from chemicals, such as bleach. Attacks may occur seasonally or upon exposure to cats in allergic patients. Exercise can also make the symptoms worse.<br></br></p>
<p>Recognise the signs of asthma on physical examination.<br></br></p>
<p>The examination may be normal in patients with bronchial asthma. Examination of the nasal passages may reveal nasal polyposis or nasal congestion. Chest auscultation may reveal expiratory wheezes.<br></br>With more severe asthma, wheezes may be audible without the use of a stethoscope. In patients with severe exacerbations, the lung examination may be silent.<br></br></p>
<p>Identify appropriate investigations for asthma and interpret the results.<br></br></p>
<p>FEV1/FVC ratio - <80% of predicted<br></br>FEV1 - 20% drop is indicative<br></br>Peak expiratory flow rate (PEFR)<br></br>CXR - normal or hyperinflated<br></br>FBC - normal or raised eosinophils and neutrophils<br></br></p>
<p>Generate a management plan for asthma.<br></br></p>
<p>Salbutamol inhaler until in hospital.<br></br>Once in hospital, administer 2.5mg salbutamol and oxygen as a nebuliser back to back (or 5mg in one dose but this increases the risk of tremor etc). Give IV hydrocortisone or oral prednisolone depending on how bad the patient is.<br></br></p>
<p>Identify the possible complications of asthma and its management.<br></br></p>
<p>IV magnesium sulfate in life-threatening exacerbation of asthma.<br></br>Airway remodelling due to inflammation which leads to the airway resembling COPD.<br></br></p>
<p>Summarise the prognosis for patients with asthma.<br></br></p>
<p>People with asthma have the same life expectancy as normal people.<br></br></p>
<p>Define acute cardiac failure.<br></br></p>
<p>Heart failure is defined clinically as a syndrome in which patients have symptoms and signs resulting from an abnormality of cardiac structure and/or function. Acute heart failure refers to rapid onset or worsening of symptoms and/or signs of heart failure, requiring urgent evaluation and treatment.<br></br></p>
<p>Explain the aetiology/risk factors of acute cardiac failure.<br></br></p>
<p>Decompensation of pre-existing chronic heart failure<br></br>Other heart conditions such as aortic regurgitation<br></br>Lack of compliance with medical treatment<br></br>Volume overload<br></br>Infections<br></br>Severe brain insult<br></br>After major surgery<br></br>Reduction of renal function<br></br>Drug abuse<br></br>Phaeochromocytoma<br></br>High output syndromes (Septicaemia, Thyrotoxic crisis, Anaemia, Shunt syndromes)<br></br></p>
<p>Summarise the epidemiology of acute cardiac failure.</p>
<p>Heart failure is the most common indication for hospitalisation in the US, and acute decompensated heart failure is the most common cause for hospitalisation among patients >65 years.<br></br>The average age of people with heart failure in studies conducted in Europe is also older than 70 years, with slight predominance of men.<br></br></p>
<p>Recognise the presenting symptoms of acute cardiac failure.<br></br></p>
<p>Dyspnoea<br></br>Decreased exercise tolerance<br></br>Swelling of the legs<br></br>Fatigue<br></br>Generalised weakness<br></br></p>
<p>Recognise the signs of acute cardiac failure on physical examination.</p>
<p>Reduced cardiac output<br></br>Tissue hypoperfusion<br></br>Increased pulmonary pressure<br></br>Tissue congestion<br></br>Raised JVP<br></br></p>
<p>Identify appropriate investigations for acute cardiac failure and interpret the results.<br></br></p>
<p>ECG<br></br>Echocardiogram<br></br>CXR<br></br>Hb<br></br>TFT<br></br>Troponin<br></br>B-type natriuretic peptide (BNP)<br></br></p>
<p>Generate a management plan for acute cardiac failure.<br></br></p>
<p>Loop diuretic in order to get rid of oedema, and then ACEi after the patient stabilises.<br></br>Treatment is generally with ACEi and beta blockers.<br></br></p>
<p>Identify the possible complications of acute cardiac failure and its management.<br></br></p>
<p><strong>ARRHYTHMIAS</strong><br></br>Hypotension, hyperkalaemia and headaches may result from treatment.<br></br></p>
<p>Summarise the prognosis for patients with acute cardiac failure.<br></br></p>
<p>In hospital, mortality ranges from 2% to 20% depending on clinical factors found on admission.<br></br>Predictors of adverse outcomes include: hypotension, renal dysfunction, older age, male sex, ischaemic congestive heart failure (CHF), previous CHF, respiratory rate on admission >30/minute, anaemia, hyponatraemia, elevated troponin, elevated B-type natriuretic peptide, and other comorbidities such as cancer.<br></br></p>
<p>Define burns injury.</p>
<p>Burns are very common injuries, predominantly to the skin and superficial tissues, caused by heat from hot liquids, flame, or contact with heated objects, electrical current, or chemicals.</p>
<p>Explain the aetiology/risk factors of burns injury.</p>
<p>Thermal burns<br></br>Electrical burns<br></br>Chemical burns<br></br>Non-accidental burns</p>
<p>Summarise the epidemiology of burns injury.</p>
<p>In the UK, 250,000 people are injured by burns. Approximately 175,000 people visit accident and emergency departments with burn injuries. Around 13,000 of them are admitted to hospital for treatment.</p>
<p>Recognise the presenting symptoms of burns injury. Recognise the signs of burns injury on physical examination.</p>
<p>Pain<br></br>Redness</p>
<p>Identify appropriate investigations for burns injury and interpret the results.</p>
<p>Full blood count<br></br>Metabolic panel<br></br>Carboxyhaemoglobin<br></br>Arterial blood gas<br></br>Fluorescein staining<br></br>Computed tomography scan of head and spine<br></br>Wound biopsy culture<br></br>Wound histology</p>
<p>Define cardiac arrest.</p>
<p>Sudden loss of cardiac systolic function. It is the result of 4 specific cardiac rhythm disturbances: <strong>ventricular fibrillation (VF), pulseless ventricular tachycardia (VT), pulseless electrical activity, and asystole</strong>. Each of these rhythms may present in different clinical scenarios, though VT and VF are the most common causes of sudden cardiac arrest.<br></br></p>
<p>Explain the aetiology/risk factors of cardiac arrest.</p>
<p>Myocardial ischaemia/infarction</p>
<p>Hypovolaemia</p>
<p>Hypoxia</p>
<p>Pulmonary embolism.</p>
<p></p>
<p>Other potential causes of cardiac arrest, all of which require emergent treatment, including hyperkalaemia, hydrogen ion excess (acidosis), hypothermia, hypo- or hyperglycaemia, trauma, tension pneumothorax,toxins, and cardiac tamponade.</p>
<p>Summarise the epidemiology of cardiac arrest.<br></br></p>
<p>In Europe, out-of-hospital cardiac arrest incidence for patients considered for resuscitation by emergency medical services has been reported as 84 per 100,000 population per year.<br></br>Survival is estimated at <20% for patients presenting out-of-hospital with VF, and <10% overall for patients presenting with out-of-hospital cardiac arrest. In contrast, 36% of patients with VF/ventricular tachycardia (VT) and 11% of patients with pulseless electrical activity/asystole, presenting in-hospital, survive to discharge.<br></br></p>
<p>Recognise the presenting symptoms of cardiac arrest. Recognise the signs of cardiac arrest on physical examination.<br></br></p>
<p>Family history of sudden cardiac arrest<br></br>Pulmonary disease<br></br>Chest pain<br></br>Palpitations- possibility of pre-existing arrhythmias<br></br>Syncope<br></br>Tachycardia<br></br>Unusual heart sounds</p>
<p>Identify appropriate investigations for cardiac arrest and interpret the results.<br></br></p>
<p>ECG<br></br>FBC<br></br>Serum electrolytes<br></br>ABG<br></br>Cardiac biomarkers<br></br>Toxicology screen<br></br>CXR<br></br>Echocardiogram<br></br>Coronary angiography<br></br></p>
<p>Generate a management plan for cardiac arrest.<br></br></p>
<p><strong>INITIAL</strong><br></br>CPR</p>
<p><strong>ACUTE</strong><br></br>Shockable rhythms (pulseless ventricular tachycardia or ventricular fibrillation)<br></br>CPR and defibrillation<br></br>Adrenaline (epinephrine)<br></br>Adjunct<br></br>Magnesium<br></br>Anti-arrhythmic</p>
<p><strong>Non-shockable rhythms (pulseless electrical activity or asystole)</strong><br></br>CPR and adrenaline (epinephrine)</p>
<p><strong>ONGOING</strong><br></br>Return of spontaneous circulation<br></br>Post-resuscitation care<br></br>No return of spontaneous circulation<br></br>Continue or consider termination of resuscitation<br></br></p>
<p>Identify the possible complications of cardiac arrest and its management.</p>
<p>Death</p>
<p>Rib and sternal fractures</p>
<p>Anoxic brain injury</p>
<p>Ischaemic liver injury (“shock liver”)</p>
<p>Renal acute tubular necrosis (ATN)</p>
<p>Recurrent cardiac arrest</p>